RHHBY Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 22:59):

Stats
Dzisiejszy wolumen	4.82M
Średni wolumen	2.81M
Kapitalizacja rynkowa	194.12B
EPS	$0.460 ( 2007-02-07 )
Następna data zysków	( $0 ) 2024-06-18
Last Dividend	$1.287 ( 2023-03-16 )
Next Dividend	$0 ( N/A )
P/E	15.30
ATR14	$0.00900 (0.03%)

Wolumen Korelacja

Długi: 0.14 (neutral)

Krótki: -0.59 (weak negative)

Signal:(46.791) Neutral

Roche Holding AG Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Roche Holding AG Korelacja - Waluta/Towar

0.22
( neutral )

0.49
( neutral )

0.00
( neutral )

0.38
( neutral )

0.23
( neutral )

Roche Holding AG Finanse

Annual	2023
Przychody:	$60.44B
Zysk brutto:	$44.08B (72.94 %)
EPS:	$14.39

FY	2023
Przychody:	$60.44B
Zysk brutto:	$44.08B (72.94 %)
EPS:	$14.39

FY	2022
Przychody:	$63.28B
Zysk brutto:	$42.88B (67.77 %)
EPS:	$15.53

Financial Reports:

No articles found.

Roche Holding AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$1.287 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Roche Holding AG Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.61 - Stable (7.89%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.211	2005-02-28
Last Dividend	$1.287	2023-03-16
Next Dividend	$0	N/A
Payout Date	2023-03-27
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	$16.76	--
Avg. Dividend % Per Year	0.00%	--
Score	2.88	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.61
Div. Directional Score	7.32	--

Next Divdend (Est)
(2024-12-31)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.88

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
YKLTF	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
MCRAB	Ex Dividend Knight	2023-09-20	Quarterly	0.00%
CLLNY	Ex Dividend Junior	2023-06-16	Semi-Annually	0.00%
SRCU	Ex Dividend Knight	2023-08-14	Quarterly	0.00%
HCBN	Ex Dividend Knight	2023-10-03	Quarterly	0.00%
AILLO	Ex Dividend Knight	2023-07-14	Semi-Annually	0.00%
NTOIY	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
CRZBY	Ex Dividend Junior	2023-06-01	Sporadic	0.00%
TMSNY	Ex Dividend Junior	2023-05-05	Annually	0.00%
IFJPY	Ex Dividend Junior	2023-08-10	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.194	1.500	6.12	9.18	[0 - 0.5]
returnOnAssetsTTM	0.191	1.200	3.65	4.37	[0 - 0.3]
returnOnEquityTTM	0.618	1.500	4.25	6.37	[0.1 - 1]
payoutRatioTTM	0.442	-1.000	5.58	-5.58	[0 - 1]
currentRatioTTM	1.347	0.800	8.26	6.61	[1 - 3]
quickRatioTTM	1.026	0.800	8.67	6.94	[0.8 - 2.5]
cashRatioTTM	0.217	1.500	9.91	10.00	[0.2 - 2]
debtRatioTTM	0.340	-1.500	4.33	-6.49	[0 - 0.6]
interestCoverageTTM	30.48	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	29.53	2.00	0.158	0.315	[0 - 30]
freeCashFlowPerShareTTM	21.35	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	1.050	-1.500	5.80	-8.70	[0 - 2.5]
grossProfitMarginTTM	0.734	1.000	1.092	1.092	[0.2 - 0.8]
operatingProfitMarginTTM	0.284	1.000	6.32	6.32	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.765	1.000	6.86	6.86	[0.2 - 2]
assetTurnoverTTM	0.983	0.800	6.78	5.42	[0.5 - 2]
Total Score				10.03

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	1.247	1.000	9.98	0	[1 - 100]
returnOnEquityTTM	0.618	2.50	6.30	6.37	[0.1 - 1.5]
freeCashFlowPerShareTTM	21.35	2.00	2.88	10.00	[0 - 30]
dividendYielPercentageTTM	5.81	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	29.53	2.00	0.158	0.315	[0 - 30]
payoutRatioTTM	0.442	1.500	5.58	-5.58	[0 - 1]
pegRatioTTM	0.0737	1.500	-2.84	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.265	1.000	5.88	0	[0.1 - 0.5]
Total Score				4.61

Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.